Daily BriefsECM

Daily Brief ECM: I-Tail Corporation IPO Trading – Should Be Able to Provide Some Holiday Cheer and more

In today’s briefing:

  • I-Tail Corporation IPO Trading – Should Be Able to Provide Some Holiday Cheer
  • I-Tail Corporation IPO: Trading Debut
  • Tian Tu Capital Pre-IPO – The Negatives – Hampered by Weakened Market Sentiment. Guiding Weak FY22
  • Sunshine Insurance Group IPO: Trading Debut
  • Growatt IPO: PHIP Update
  • VinFast Auto IPO: The Bull Case
  • VinFast Auto Pre-IPO – The Negatives – … But Starting Low
  • PagerDuty Inc: Major Drivers
  • Pre-IPO Medbanks Network Technology – PHIP Updates: The Business Model Has yet to Be Verified
  • Box Inc: Major Drivers, Financial Forecasts, DCF & Comparables Valuation, Key Risks (12/22)

I-Tail Corporation IPO Trading – Should Be Able to Provide Some Holiday Cheer

By Sumeet Singh

  • I-Tail, an OEM in the wet pet food category, raised around US$600m in its Thailand IPO. It is a subsidiary of Thai Union Group (TU TB).
  • As per ITC, it was the number two pet food company in Asia and in the top ten pet food companies globally. ITC expertise lies in fish-based wet pet food.
  • In our previous notes, we have looked at the company’s past performance, undertaken a peer comparison and spoken about valuation. In this note, we will talk about the trading dynamics

I-Tail Corporation IPO: Trading Debut

By Arun George


Tian Tu Capital Pre-IPO – The Negatives – Hampered by Weakened Market Sentiment. Guiding Weak FY22

By Clarence Chu

  • Tian Tu Capital (1390587D CH) is looking to raise US$300m in its upcoming Hong Kong IPO.
  • Tiantu Capital (TTC) is a private equity/venture capital investor and fund manager with a focus on Chinese consumer brands and companies.
  • The fund manages capital from investors including institutional investors, multinational corporations, financial institutions, and high net-worth individuals. It also directly invests through its own capital as well.

Sunshine Insurance Group IPO: Trading Debut

By Arun George


Growatt IPO: PHIP Update

By Shifara Samsudeen, ACMA, CGMA

  • Growatt is a distributed energy solution provider with the #1 market share for PV inverters and energy storage inverters, allowing them strong potential to benefit from a growing market.
  • In November 2022, the company received approval from the Hong Kong Stock Exchange and the IPO has a placeholder value of US$1bn, making it HKEX’s fourth largest IPO of 2022.
  • In this follow-up insight, we have highlighted and discussed some of the key new data points from the company’s latest Post Hearing Information Pack (PHIP).

VinFast Auto IPO: The Bull Case

By Arun George

  • VinFast (1905332D VN), a Vietnamese EV (electric vehicle) manufacturer and a majority-owned affiliate of Vingroup Jsc (VIC VN), has filed for a US$1.0 billion IPO to list on Nasdaq.
  • VinFast is in the middle of a transition from an ICE to a pure-play EV manufacturer. VF 8, its second EV SUV, will be delivered in the US in 4Q22. 
  • The key elements of the bull case rest on a credible EV roadmap, speed-to-market, solid consumer interest and models with attractive range-to-price ratios and total cost of ownership.

VinFast Auto Pre-IPO – The Negatives – … But Starting Low

By Sumeet Singh

  • VinFast (1905332D VN)  is looking to raise up to US$1bn in its upcoming US IPO.
  • VinFast is a full-scale mobility platform focused primarily on designing and manufacturing premium EVs, electric scooters and electric buses.
  • In this note, we talk about the not-so-positive aspects of the deal.

PagerDuty Inc: Major Drivers

By Baptista Research

  • PagerDuty performed well in the last quarter despite the relatively uncertain environment and delivered an all-around beat.
  • The company saw a good performance in financial services, tech retail, and other verticals.
  • Total paid and free customers on its platform grew, and consumers continued to adopt more products and services and expand users.

Pre-IPO Medbanks Network Technology – PHIP Updates: The Business Model Has yet to Be Verified

By Xinyao (Criss) Wang

  • Specialty Pharmacy Business is the main revenue contributor,but it’s hard for Medbanks to achieve breakeven or turn loss into profits by relying on this business due to its low margin.
  • Physician Research Assistance and Health Insurance Services have higher margin, but they have to face different challenges based on our analysis. They are hard to turn things around.
  • In fact, Medbanks does not control the core resources or establish high barriers in front of competition. Whether its ecological story would finally work still needs time to verify. 

Box Inc: Major Drivers, Financial Forecasts, DCF & Comparables Valuation, Key Risks (12/22)

By Baptista Research

  • Box had a mixed third quarter, with revenue below Wall Street expectations but stronger than expected earnings.
  • Their leading security and data governance tools, Box Governance and Box Shield have received many significant upgrades.
  • The Box Shield ethical wall feature was also made public during the quarter.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars